Amarin Corporation plc (AMRN) financial statements and ratios from SEC XBRL: revenue $0.2B (TTM), net margin -18.2%, revenue growth -42.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $213.65M |
| Revenue (TTM) | $0.2B |
| Net Margin | -18.2% |
| Return on Equity | -6.1% |
| Operating Margin (TTM) | -21.9% |
| Current Ratio | 3.67 |
| Revenue Growth (YoY) | -42.0% |
| EPS Growth (YoY) | -33.3% |
| Altman Z-Score | 13.66 (safe) |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Sector P/E (Healthcare) | 21.6 |
AMRN overview · AMRN earnings · AMRN KPIs · AMRN documents · AMRN ownership · AMRN peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.